Genenta Science
GNTA
4 hedge funds and large institutions have $264K invested in Genenta Science in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
1,455% more capital invested
Capital invested by funds: $17K → $264K (+$247K)
100% more funds holding
Funds holding: 2 → 4 (+2)
0.25% more ownership
Funds ownership: 0.02% → 0.27% (+0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AU
Algebris (UK)
London,
United Kingdom
|
+$222K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.69K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$922 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AU
1
Algebris (UK)
London,
United Kingdom
| $242K | +$222K | +45,000 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $17.7K | +$922 | +187 | +6% |
|
3
Morgan Stanley
New York
| $2.75K | – | – | – |
|
|
4
Bank of America
Charlotte,
North Carolina
| $1.89K | +$1.69K | +343 | New |
|
GNTA Hedge Fund Activity: Q4 2022 in Review
4 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q4 2022, worth a combined $264K — up 1,455% from $17K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GNTA positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Algebris (UK), opening a new position worth an estimated $222K.
- 4 institutional investors held Genenta Science (GNTA) as of Q4 2022, up from 2 in Q3 2022.
- Funds reported $264K of Genenta Science stock for Q4 2022, up 1,455% quarter-over-quarter.
- 2 funds opened new Genenta Science positions in Q4 2022 and 0 closed out, a net change of +2 holders.
- The largest Genenta Science buyer in Q4 2022 was Algebris (UK), an estimated $222K added.
Based on aggregated 13F filings for Q4 2022.